Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan J Neth

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Neuro-Oncology Advances|October 16, 2023
Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patientsM J Webb, Bryan J Neth, Lauren M Webb, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 9, 2025
Discrepancies between CSF biomarker and PET determinations of elevated brain amyloid and their prognostic significanceDavid S Knopman, Stephen D Weigand, Heather J Wiste, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 29, 2025
Skin Biopsy for Phosphorylated α-Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology PracticeMichael J Rigby, Hugo Botha, Leland R Barnard, et al.
Mayo Clinic Proceedings|January 23, 2026
Establishing an Alzheimer Disease Therapeutics Clinic: Experience From a Year of EvaluationsBryan J Neth, Jonathan Graff-Radford, Petrice M Cogswell, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Neuro-Oncology Advances|October 16, 2023
Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patientsM J Webb, Bryan J Neth, Lauren M Webb, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 9, 2025
Discrepancies between CSF biomarker and PET determinations of elevated brain amyloid and their prognostic significanceDavid S Knopman, Stephen D Weigand, Heather J Wiste, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 29, 2025
Skin Biopsy for Phosphorylated α-Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology PracticeMichael J Rigby, Hugo Botha, Leland R Barnard, et al.
Mayo Clinic Proceedings|January 23, 2026
Establishing an Alzheimer Disease Therapeutics Clinic: Experience From a Year of EvaluationsBryan J Neth, Jonathan Graff-Radford, Petrice M Cogswell, et al.
Pageof 6